Procter & Gamble CFO Andre Schulten discusses the company's Q4 fiscal 2025 results, which beat on EPS but missed on revenue due to shipment timing, while underlying consumption grew 2.5%. He highlights record productivity of $2.8 billion, broad-based organic sales growth across regions and categories, and stabilizing market share. Guidance for the new fiscal year assumes 1-3% organic sales growth and 0-3% core EPS growth, with a $1 billion after-tax headwind from oil price and Middle East conflict, partially offset by productivity savings. The stock initially dipped on the revenue miss.